Rockefeller Capital Management L.P. Buys 52,525 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Rockefeller Capital Management L.P. raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 41.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 178,503 shares of the exchange traded fund’s stock after acquiring an additional 52,525 shares during the quarter. Rockefeller Capital Management L.P. owned approximately 0.23% of SPDR S&P Biotech ETF worth $17,636,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Comerica Bank lifted its holdings in shares of SPDR S&P Biotech ETF by 33.6% during the 1st quarter. Comerica Bank now owns 13,315 shares of the exchange traded fund’s stock valued at $1,263,000 after purchasing an additional 3,346 shares during the last quarter. Cetera Investment Advisers lifted its holdings in shares of SPDR S&P Biotech ETF by 321.8% during the 1st quarter. Cetera Investment Advisers now owns 165,220 shares of the exchange traded fund’s stock valued at $15,678,000 after purchasing an additional 126,053 shares during the last quarter. Mather Group LLC. lifted its holdings in shares of SPDR S&P Biotech ETF by 1,722.9% during the 2nd quarter. Mather Group LLC. now owns 875 shares of the exchange traded fund’s stock valued at $83,000 after purchasing an additional 827 shares during the last quarter. Lynx Investment Advisory purchased a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at $58,000. Finally, Kingswood Wealth Advisors LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 8.2% during the 2nd quarter. Kingswood Wealth Advisors LLC now owns 5,443 shares of the exchange traded fund’s stock valued at $505,000 after purchasing an additional 411 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 0.4 %

Shares of XBI opened at $99.62 on Monday. The firm has a market cap of $7.59 billion, a PE ratio of 11.47 and a beta of 1.11. The stock has a fifty day moving average price of $98.22 and a 200-day moving average price of $96.61. SPDR S&P Biotech ETF has a 12 month low of $74.20 and a 12 month high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.